Bridging expertise.
Transforming healthcare.
At velella, we unite medical science, digital innovation, and human insight to co-create healthcare solutions that improve lives. Working with patients, healthcare professionals, and industry partners, we deliver compliant, impactful outcomes.
We aim to be trusted partners in medical communication and digital transformation – shaping a future where every patient has access to informed, personalized care.
To achieve this, we create digital health and education solutions with medical and patient communities, combining scientific rigor with creative innovation.
Why Leading Pharma Companies choose velella
Experience
We combine consulting expertise, digital innovation, and pharmaceutical know-how with scientific depth across therapeutic areas.
Client-Focus
By co-creating with clients, patients, and medical communities, we ensure every solution is credible, compliant, and impactful.
End-to-end
Our specialists – from strategists to medical writers, designers and developers – work as one integrated team, turning insight into measurable outcomes.
Want to know more about us?
What We Do
End-to-end consulting and implementation services focused on patient-centered healthcare. We bridge medical, digital, and creative expertise to turn complex challenges into measurable outcomes.
Thought Leadership in Medical Affairs
Strategic guidance and scientific excellence that strengthen your credibility and impact
- Learn more
Medical Education & Communications
Engaging educational programs that transform complex science into meaningful learning
- Learn more
Digital & Emerging Technology Solutions
Innovative digital platforms that enhance patient care and outcomes
- Learn more
Our Proven 4-Phase Methodology
Every project follows our structured co-creation approach, ensuring
stakeholder alignment and measurable outcomes.
Partners in Healthcare Innovation
Discover how we’ve helped leading pharmaceutical and healthcare companies transform patient care
Scientific Slide Deck Development
From mechanism of action designs to epidemiological data, our team can support a wide variety of detailed scientific and medical concepts. Recently, we completed a slide deck covering KMT2Ar and NPM1 Acute Myeloid Leukemia. This included mechanism of action designs, the epidemiology of the disease, an overview of current studies, available treatments and more- all tailored to the client’s specific needs. Other examples of our work include epidemiological research after the 2021 WHO Glioma re-classification, surgery options and incidence for low-grade glioma (LGG), and Non-small cell lung cancer (NSCLC) patient pathway visualization.